Table 2.
Clinical characteristics of 1159 study participants at the Mulago HIV clinic in Uganda between April 2012 and December 2013
| Characteristic | Whole sample | ART | No ART |
|---|---|---|---|
| n = 1159 (%) | n = 586 (%) | n = 573 (%) | |
| WHO disease stage | |||
| Stages I and II | 962 (83) | 470 (80) | 492 (86) |
| Stages III and IV | 197 (17) | 116 (20) | 81 (14) |
| Opportunistic infection | |||
| Yes | 310 (27) | 187 (32) | 123 (21) |
| No | 849 (73) | 399 (68) | 450 (79) |
| Depression screening, baseline score | |||
| No depression (<16) | 777 (67) | 380 (65) | 397 (69) |
| Probable depression (≥16) | 382 (33) | 206 (35) | 176 (31) |
| Depression screening score, 6 months | |||
| No depression (<16) | 845 (73) | 443 (76) | 402 (70) |
| Probable depression (≥16) | 314 (27) | 143 (24) | 171 (30) |
| Baseline CD4 count (cells/μL) | |||
| <100 | 104 (9) | 104 (18) | 0 (0) |
| 101–350 | 436 (38) | 436 (74) | 0 (0) |
| >350 | 619 (53) | 46 (8) | 573 (100) |
| CD4 count at 6 months | |||
| <100 | 27 (2) | 26 (4) | 1 (0) |
| 101–350 | 205 (18) | 179 (31) | 26 (5) |
| >350 | 927 (80) | 381 (65) | 546 (95) |
Abbreviation: ART, antiretroviral therapy